High-dose chemotherapy (HDCT) with G-CSF support before radiotherapy (RT) in malignant gliomas (MG):: Phase II trial

被引：0
|
作者：
Viñolas, N
Gil, M
Verger, E
Villá, S
Pujol, T
Caral, L
García, M
Graus, F
Estapé, J
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Inst Catala Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80869-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
435
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234
    Vogelzang, NJ
    Herndon, JE
    Miller, A
    Strauss, G
    Clamon, G
    Stewart, FM
    Aisner, J
    Lyss, A
    Cooper, MR
    Suzuki, Y
    Green, MR
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 597 - 600
  • [2] Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients
    Straka, C
    Oduncu, F
    Hinke, A
    Einsele, H
    Drexler, E
    Schnabel, B
    Arseniev, L
    Walther, J
    König, A
    Emmerich, B
    BLOOD, 2004, 104 (07) : 1989 - 1994
  • [3] Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer
    De Rosa, L
    Lalle, M
    Perillo, A
    Pierelli, L
    Salerno, MG
    Cortesi, E
    Martelli, O
    Pandolfi, A
    Amodeo, R
    Marzetti, L
    Mancuso, S
    Scambia, G
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1367 - 1370
  • [4] CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF
    TARELLA, C
    CARACCIOLO, D
    GAVAROTTI, P
    BENEDETTI, G
    BONDESAN, P
    CASTELLINO, C
    CHERASCO, C
    PILERI, A
    BLOOD, 1993, 82 (10) : A654 - A654
  • [5] Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: A phase II trial
    Flores, Raja M.
    Krug, Lee M.
    Rosenzweig, Kenneth E.
    Venkatraman, Ennapadam
    Vincent, Alain
    Heelan, Robert
    Akhurst, Tim
    Rusch, Valerie W.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (04) : 289 - 295
  • [6] Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.
    Baer, Maria R.
    Ford, Laurie A.
    Bundy, Brian N.
    Tighe, Sheila M.
    O'Loughlin, Kieran L.
    Slack, James L.
    Wetzler, Meir
    Wallace, Paul K.
    BLOOD, 2006, 108 (11) : 223B - 223B
  • [7] High-dose chemotherapy (HDCT) and autologous transplant (AT) in non Hodgkin's lymphoma (NHL):: Survival and Tolerance after consolidative radiotherapy (RT).
    Belkacémi, Y
    Fouillard, L
    Piel, G
    Laporte, JP
    Pène, F
    Lesage, S
    Touboul, E
    Isnard, F
    Aoudjane, M
    Huart, J
    Najman, A
    Gorin, NC
    Housset, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S170 - S170
  • [8] SERUM CONCENTRATIONS OF G-CSF DURING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE
    MIKSITS, K
    BEYER, J
    SIEGERT, W
    BONE MARROW TRANSPLANTATION, 1993, 11 (05) : 375 - 377
  • [9] MULTIPLE HIGH-DOSE CHEMOTHERAPY CYCLES SUPPORTED BY PERIPHERAL-BLOOD PROGENITOR CELLS AND G-CSF
    CHAO, NJ
    LONG, GD
    NEGRIN, RS
    KUZNIERZGLAS, C
    BLUME, KG
    BLOOD, 1993, 82 (10) : A349 - A349
  • [10] PBPC mobilization in multiple myeloma: High-dose chemotherapy plus G-CSF vs two different dosages of G-CSF during steady-state.
    Goldschmidt, H
    Hegenbart, U
    Cremer, F
    Kiel, K
    Wallmeier, M
    Hohaus, S
    Haas, R
    Moos, M
    BLOOD, 1996, 88 (10) : 1610 - 1610
12345